Fingerprint
Dive into the research topics where Zheng Xia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
CD4+ T Cells Mediate MHC-Deficient Tumor Rejection and Endothelial Cell Reprogramming
Kim, S. I., Haerr, M. E., Al-Ghezi, M., Chen, C., Zhang, Y., Phipps, J. L., Arora, C., Gribbin, K. P., Kim, G., Markosyan, N., Xia, Z., Vonderheide, R. H. & Byrne, K. T., Jan 1 2026, In: Cancer Immunology Research. 14, 1, p. 107-121 15 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Scopus citations -
Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types
Hu, Y. M., Zhao, F., Graff, J. N., Chen, C., Zhang, Y., Stommel, J. M., Lee, J., Zangirolani, G. M., Rose, J., Thomas, G. V., Wu, H., Kardosh, A., Mills, G. B., Alumkal, J. J., Moran, A. E. & Xia, Z., Jan 1 2026, In: Cancer Research Communications. 6, 1, p. 17-35 19 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Commentary: Enhanced prediction of breast cancer patient response to chemotherapy by integrating deconvolved expression patterns of immune, stromal and tumor cells
Yang, X. & Xia, Z., Dec 28 2025, In: Cancer Letters. 635, 218108.Research output: Contribution to journal › Editorial › peer-review
-
MBNL loss of function in smooth muscle as a model for myotonic dystrophy associated gastrointestinal dysmotility
Peterson, J. A. M., Frias, J. A., Miller, A. N., Soni, K. G., Zhang, Y., Xia, Z., Day, J. W., Preidis, G. A. & Cooper, T. A., Dec 16 2025, In: Proceedings of the National Academy of Sciences of the United States of America. 122, 50, e2522788122.Research output: Contribution to journal › Article › peer-review
Open Access -
Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer
Kumaraswamy, A., Hu, Y. M., Yates, J. A., Zhang, C., Rodansky, E., Khokhani, D., Flores, D., Duan, Z., Zhang, Y., Tabatabaei, S., Slottke, R., Ye, S., Lara, P., Foye, A., Ryan, C. J., Quigley, D. A., Huang, J., Aggarwal, R., Reiter, R. E. & Wicha, M. S. & 11 others, , Dec 1 2025, In: npj Precision Oncology. 9, 1, 223.Research output: Contribution to journal › Article › peer-review
Open Access